GenCC GmbH

Startup

GenCC GmbH & Co. KG, based in Darmstadt, Germany, specializes in alternative expression systems to produce recombinant proteins. By utilizing innovative platforms—including plants, insects, and other non-traditional systems—GenCC develops high-quality, complex biomolecules at competitive costs.

Our cutting-edge molecular pharming technologies are designed to transform the biopharmaceutical, food, and cosmetics industries, enabling researchers and manufacturers to bring innovations to market faster and more cost-effectively. Our solutions support a wide range of applications, including biotechnology, gene and cell therapy, and specialty protein production.

From mRNA vaccines to enzymes, growth factors, cytokines or antibodies, our platforms enable the production of complex molecules with proper folding, glycosylation, and post-translational modifications, ensuring their efficacy and bioactivity. Furthermore, our plant-based expression systems offer a unique advantage for vaccine manufacturing, as they are safe for human use and eliminate the risk of human virus contamination. Operating under cGMP and ISO compliance, we provide a scalable and flexible approach.

Our vision is to become the leading partner for vaccines and specialty protein production, empowering our partners with safe, efficient, and cost-effective solutions. At World Vaccine Congress Amsterdam 2025, we look forward to collaborating with industry leaders to advance vaccine research and production.